FMS · Fresenius Medical Care AG
$24.86
+0.11 (+0.44%)
At close · Jul 29
Market Cap
$13.35B
Shares
537.13M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.97B
FY2013
Net Income
$1.11B
-6.5%
FY2013
Gross Margin
95.33%
FY2013
Operating Margin
45.39%
FY2013
Diluted EPS
$3.65
FY2013
Operating Cash Flow
$2.03B
-0.2%
FY2013
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|
| — | $4.97B | — | — | — | — | |
| EUR | — | 408.56M | — | -296.53M | — | — |
| $21.17B | $9.87B | $9.2B | $8.27B | $7.91B | $7.42B | |
| $9.97B | $4.74B | $4.6B | $4.52B | $4.14B | $3.83B | |
| — | 95.33% | — | — | — | — | |
| $282.5M | $125.81M | $111.63M | $110.83M | $96.53M | $93.81M | |
| $5.32B | $2.39B | $2.22B | $2.37B | $2.12B | $1.98B | |
| — | $93.1M | — | — | — | — | |
| $960.11M | $648.23M | $602.9M | $557.28M | $503.22M | $457.09M | |
| $4.49B | $2.26B | $2.22B | $2.07B | $1.92B | $1.76B | |
| — | 45.39% | — | — | — | — | |
| $5.45B | $2.9B | $2.82B | $2.63B | $2.43B | $2.21B | |
| $798.33M | $447.5M | $470.53M | $356.36M | $305.47M | $321.36M | |
| $28M | $38.94M | $44.47M | $59.83M | $25.41M | $21.4M | |
| — | — | — | $0 | — | — | |
| -$40.98M | -$26.11M | -$17.44M | $30.96M | — | — | |
| $3.78B | $1.85B | $1.93B | $1.78B | $1.64B | $1.46B | |
| $1.15B | $592.01M | $605.14M | $601.1M | $578.35M | $490.41M | |
| $2.1B | $1.11B | $1.19B | $1.07B | $978.52M | $891.14M | |
| — | 22.33% | — | — | — | — | |
| $523.03M | $145.73M | $140.17M | $106.11M | $86.88M | $74.08M | |
| $2.28B | $1.05B | $1.18B | $779.43M | $834.2M | $992.7M | |
| USD/shares | — | $3.65 | — | $3.54 | $3.25 | $2.99 |
| USD/shares | — | $3.65 | — | $3.51 | $3.24 | $2.99 |
| shares | — | 301.88M | 301.14M | 299.01M | 296.81M | — |
| shares | — | 302.55M | 302.9M | 300.81M | 298.12M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2013: $1.31B in dividends.
Key facts
CIK
1333141
CUSIP
358029106
13F (30d)
79 filings
67 filers
Visit website
Investor relations